Poison Pill Increasingly A Tough Call

Law360, New York (October 7, 2009, 1:17 PM EDT) -- Weighing whether to adopt or extend a poison pill as part of a takeover defense strategy has become an increasingly complicated process for public companies, and recent pushes for corporate governance reforms promise to make the decision even more complex, experts say.

It’s a decision that a number of public companies have to face this year: More than 200 companies have a decade-old poison pill set to expire, according to data released by FactSet SharkRepellent, a tracker of takeover defenses.

A typical poison pill used to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.